Symmetric
  • TRAINING COURSES
  • IN-HOUSE TRAINING
  • CLIENTS
  • TRAINERS
  • BLOG
  • ABOUT US
  • CONTACT

Join Symmetric Newsletter

Sign up today so you don't miss any special offers, new events and pharma breaking news.

TOP 3 Pharma & Biotech Worldwide News Once a Month

Interviews With Industry Professionals Once Every Three Months

Regular Event Calendar & Special Offers Once Every Six Months

Symmetric s.r.o.

Mliekarenska 7

82109 Bratislava

Slovak Republic

ID: 47 068 124

VAT No: SK2023741973

Office: +421 948 262 346

LinkedIn

Booking & Support

Phone (EU):+421 948 262 346 (9:00 - 17:00 CET)

Phone (US):+1 857 392 2714 (9:00 - 16:00 ET)

Email:info@symmetric.events

A real member of our team answers our chat

Terms & ConditionsPrivacy PolicyChange Your Cookie Consent

© 2026 Symmetric s.r.o.

Value Added Medicines / Scientific, Regulatory and IP Analysis
Pharma & Biotech

Value Added Medicines / Scientific, Regulatory and IP Analysis

Date to be announced

Contact us for more info
Price available after dates are announced

TRAINING TIMES

  • TBDVienna
  • TBDLondon
  • TBDNew York
  • TBDLos Angeles
Online Training



LEARNING OBJECTIVES

Learning Objective

The concept of value in the health care environment

The concept of value in the health care environment

Learning Objective

Analyze the market before embarking on an added value strategy

Analyze the market before embarking on an added value strategy

Learning Objective

Create viable business models in different markets

Create viable business models in different markets

Learning Objective

Is repositioning a high-risk strategy – when could it be suitable for your company?

Is repositioning a high-risk strategy – when could it be suitable for your company?

Learning Objective

How to differentiate a generic product

How to differentiate a generic product

Learning Objective

Select the right route to drug approval

Select the right route to drug approval

Learning Objective

What type of products to stay away from because of clinical barriers

What type of products to stay away from because of clinical barriers

Learning Objective

An in-depth scientific discussion of different mechanisms that could lead to an added value product

An in-depth scientific discussion of different mechanisms that could lead to an added value product

Learning Objective

Case studies of Formulation patents – successes and failures

Case studies of Formulation patents – successes and failures

Learning Objective

Consequences of market switch from Brand to INN generics

Consequences of market switch from Brand to INN generics



KEY TOPICS

Innovative Generic Business Development
A concept of value in health care environment
Market Access for Value Added Medicines
Drug Repositioning / Repurposing
Scientific and Technological solutions for Value Added Medicines
Clinical aspects
IP and data exclusivity
Formulation patents: successes and failures